Full Version | Search

The Irish Medicines Board - www.imb.ie

Legislation

Links

Events

News

Consultation

Contact Us

Recruitment

Privacy

Contacts

Disclaimer

FAQs

About Us
- Organisational Structure
  - Board & Committees
    - Board Members
  - Management
    - Management Committee Members
- Freedom of Information
- Working with the IMB
- Customer Service
- Quality Management
- Location

Copyright

Safety & Quality
- Advisory, Warning & Recall Notices
  - Human Medicines
    - Important Safety Warning: Relenza inhalation powder must not be nebulised or administered by mechanical ventilation.
  - Medical Devices
  - Blood, Tissues & Cells
  - Veterinary Medicines
- How the IMB monitors product safety
  - Human Medicines
    - Drug Safety
    - Market Compliance
    - Defects in Medicines
  - Medical Devices
  - Tissues & Cells
  - Blood
  - Veterinary Medicines
- Reporting Suspected Product Problems
  - Safety Related Problems
  - Quality Related Problems
  - Product Recalls
- Online Forms
  - Human Medicine -Adverse Reaction
  - Clinical Trial-Serious Adverse Event
  - Tissues&Cells-Adverse Reaction/Event
  - Quality Defect
  - Medical Device Incident User Report Form
  - Veterinary Medicine - Adverse Reaction
  - Gardasil Adverse Reaction

Human Medicines
- New EU Pharmacovigilance Legislation
- HPV School Immunisation
  - Product Information
  - Possible Side Effects of Vaccination
  - Reporting Suspected Side Effects
  - National Monitoring Overview
  - Further Information
- Pandemic (H1N1) 2009
  - Anti-viral Medication
  - ADR Reporting
  - Counterfeit Medication
- Human Medicines
  - Licensing
    - New Product
    - Variation
    - Renewal
    - Transfer
    - Withdrawal
    - Parallel Importation
    - Homeopathics
    - Periodic Safety Updates
    - Fees
    - On-Line Applications
    - test
    - Legal Supply Status and Reclassification
  - Herbal Medicines
  - Traditional Herbal Medicines Registration
  - Homeopathic Medicines
  - Vaccines
  - Human Medicines Listing
  - Drug-Device Combination Products
  - Advertising of human medicinal products
  - Notification System for Exempt (unauthorised) Products
- Clinical Trials
  - Good Clinical Practice (GCP)
  - Licensing
  - Serious Adverse Event form
- Manufacturing
  - Licensing
    - New Applications
    - Renewals
    - Variation Application
    - Transfers
  - Authorised Manufacturers List
- Laboratory
- Wholesale Distribution
  - Licensing
    - New Applications
    - Variation Applications
    - Renewal Applications
  - Authorised Wholesalers List
- Export Certification
- Controlled Drugs and Precursor Chemicals
- Classification of Medicines

Veterinary Medicines
- IMB Veterinary Medicines
  - Functions of the IMB
  - Advisory Committee for Veterinary Medicines
  - Organogram
  - Contact Details
- Availability of Veterinary Medicines
  - International Initiatives
  - National Initiatives
  - Exceptional Authorisations
  - Use Outside the Approved Authorisation
  - Supply and Importation
- Licensing Activities
  - New Product Application
  - IMB as RMS
  - Joint Labelling Procedure
    - Product Literature Standard
  - Partnership Initiative
  - Variation Application
  - Renewal Application
  - Transfer Application
  - Withdrawal
  - Marketing Status Notification
  - Batch Specific Request
  - Parallel Importation
  - Homeopathic Medicines
  - Herbal Medicines
  - Premixes
  - On-Line Applications
- Additional Activities
  - Borderline Products
    - Classification Enquires
  - Clinical Trials
  - Use Outside the Approved Label
- Safety
- Drug Safety
  - Monitoring of Veterinary Medicines
  - PSUR Reporting Requirements
  - Adverse Reaction Reporting
    - Eudravigilance
  - Adverse Reaction Annual Reports
  - European Pharmacovigilance Guidelines
  - Antimicrobial Resistance
- News and Publications
  - Overview of the Regulatory Process
  - Latest Safety News
  - Events
  - Recently Authorised Veterinary Medicines
  - Frequently Asked Questions
  - Guidelines and Forms
  - Newsletter
  - Fees
- Useful Links
- Veterinary Medicines Listing
- Manufacturers Listing

Medical Devices
- Pre-Market Activities
  - Clinical Investigations
  - Registration
  - Classification
  - Notified Body Management
  - Drug-Device Combination Products
- Post-Market Activities
  - Vigilance
  - Certificates of Free Sale
  - Compliance
- Auditing & Surveillance
- On-Line Services
- Information Leaflets
- Safety Notices
- SCHENIR Report: The safety of dental amalgam and alternative dental restoration materials for patien

Blood, Tissues & Cells
- Blood
  - Hospital Blood Bank Annual Report (HBBAR)
- Tissues & Cells
- Blood & Tissue Establishments

Cosmetics
- test page
- test

Publications

Patients & Public
- About the IMB
- Consumer Information & Advice
- Consumer Research
- Reporting Safety and Quality Concerns
  - Reporting a Human Medicine Side Effect
  - Reporting a Veterinary Medicine Side Effect
  - Reporting a Medicine Quality Issue
  - Reporting a Medical Device Adverse Incident
  - Reporting a Cosmetic Product Undesirable Effect
- Search for Authorised Medicines
  - Product List - Human Medicines
  - Product List - Veterinary Medicines
- Subscribe to our Updates
- Corporate Publications
- Useful Links
- Healthcomplaints.ie

Please ignore the message titled ‘New page on homeopathy’ as this was sent in error

Glossary

Date Printed: 04 February 2012

© Irish Medicines Board 2012 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971